Vanderbilt Heart and Vascular Institute Archives
Nov. 21, 2013—Ahead of its move into new space on the fifth floor of the Critical Care Tower in February, the Vanderbilt Heart and Vascular Institute has announced two key position changes.
Nov. 14, 2013—Vanderbilt Heart and Vascular Institute is participating in a clinical trial to evaluate a medical device for the treatment of coronary artery disease.
Sep. 17, 2013—Researchers at the Vanderbilt Heart and Vascular Institute and Massachusetts General Hospital have identified a biomarker that can predict diabetes risk up to 10 years before onset of the disease.
Aug. 22, 2013—Cardiac surgeons recently performed Vanderbilt Heart and Vascular Institute’s 100th ventricular assist device (VAD) implant.
Aug. 8, 2013—Vanderbilt Heart and Vascular Institute is the first in the United States to use a new fully resorbable “envelope” that encloses implantable cardiac devices, such as pacemakers and internal cardioverter defibrillators (ICDs), and helps prevent surgical site infections.
Aug. 1, 2013—People with the most common irregular heart rhythm known as atrial fibrillation (AF) are at greater risk for stroke due to the formation of clots in the left atrial appendage (LAA), a small pouch which empties blood into the left atrium.
Jul. 18, 2013—Vanderbilt Heart and Vascular Institute physicians are taking advantage of new technology in critical care that allows them to quickly visualize the patient’s heart at the bedside.
May. 9, 2013—Peggi Angel, Ph.D., research instructor in Biochemistry, studies congenital aortic valve stenosis in children. It’s a disease where the heart valve, which is normally very thin, becomes bloated with extracellular matrix. This occurs rapidly in some children but not in others.
Apr. 25, 2013—During Cardiovascular Research Day, keynote speaker Sekar Kathiresan, M.D., second from left, associate professor of Medicine, Harvard Medical School, visits with Vanderbilt Heart and Vascular Institute’s Sergio Fazio, M.D., Ph.D., left, MacRae Linton, M.D., Thomas Wang, M.D., David Harrison, M.D., and Dan Roden, M.D.
Apr. 25, 2013—Vanderbilt Heart and Vascular Institute is participating in a clinical study to further evaluate the safety and feasibility of rapidly lowering the body’s temperature to significantly reduce the amount of damage caused by a heart attack.